254 related articles for article (PubMed ID: 106097)
1. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
Feingold KR; Goldfine ID; Weinstein PR
J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
[TBL] [Abstract][Full Text] [Related]
2. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
3. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Case report.
Genka S; Soeda H; Takahashi M; Katakami H; Sanno N; Osamura Y; Fuchinoue T; Teramoto A
J Neurosurg; 1995 Oct; 83(4):719-23. PubMed ID: 7674023
[TBL] [Abstract][Full Text] [Related]
6. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
7. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in hormonal detection of pituitary somatotropic adenomas (author's transl)].
Turpin G; Heshmati HM; De Gennes JL
Ann Med Interne (Paris); 1982; 133(1):17-22. PubMed ID: 6802054
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly with normal basal growth hormone levels.
Mohr G; Chen ZP; Schweitzer M
Can J Neurol Sci; 1997 Aug; 24(3):250-3. PubMed ID: 9276113
[TBL] [Abstract][Full Text] [Related]
10. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.
Schaison G; Couzinet B; Moatti N; Pertuiset B
Clin Endocrinol (Oxf); 1983 Jun; 18(6):541-9. PubMed ID: 6411389
[No Abstract] [Full Text] [Related]
11. Somatomedin-C in active and successfully treated acromegaly.
Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
Nakagawa K; Akikawa K; Matsubara M; Kubo M
J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
[TBL] [Abstract][Full Text] [Related]
13. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
14. The treatment of acromegaly by transsphenoidal surgery.
Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly in an infant.
Blumberg DL; Sklar CA; David R; Rothenberg S; Bell J
Pediatrics; 1989 Jun; 83(6):998-1002. PubMed ID: 2657629
[TBL] [Abstract][Full Text] [Related]
16. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
Wass JA
J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between clinical and endocrinological features following transsphenoidal surgery of acromegaly. With special reference to somatomedin-C level].
Osawa M; Kobayashi S; Takemae T; Nakagawa F
Neurol Med Chir (Tokyo); 1988 Mar; 28(3):254-8. PubMed ID: 2457827
[No Abstract] [Full Text] [Related]
18. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
[TBL] [Abstract][Full Text] [Related]
19. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
[TBL] [Abstract][Full Text] [Related]
20. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
